285 related articles for article (PubMed ID: 35126610)
21. Diagnostic Accuracy of Cell Block and Immunohistochemistry in Effusion Cytology.
Batool S; Sadaf S; Chughtai AS; Qasim A; Zafar A; Jamil A
Cureus; 2023 Feb; 15(2):e34958. PubMed ID: 36938247
[TBL] [Abstract][Full Text] [Related]
22. Detection of the human telomerase RNA component by in situ hybridization in cells from body fluids.
Nieh S; Chen SF; Fu E; Jan CI; Lee WH
Acta Cytol; 2005; 49(1):31-7. PubMed ID: 15717752
[TBL] [Abstract][Full Text] [Related]
23. Optimal fluid volume for detecting malignancy in serous effusions: a single institution experience.
Beg S; Zanettini C; Queiroz L; Marchionni L; Alperstein SA; Siddiqui MT
J Am Soc Cytopathol; 2023; 12(6):415-422. PubMed ID: 37419704
[TBL] [Abstract][Full Text] [Related]
24. Wilms tumor 1/cytokeratin dual-color immunostaining reveals distinctive staining patterns in metastatic melanoma, metastatic carcinoma, and mesothelial cells in pleural fluids: an effective first-line test for the workup of malignant effusions.
Conner JR; Cibas ES; Hornick JL; Qian X
Cancer Cytopathol; 2014 Aug; 122(8):586-95. PubMed ID: 25044880
[TBL] [Abstract][Full Text] [Related]
25. The role of BRCA1-associated protein 1 in the diagnosis of malignant mesothelioma in effusion and fine-needle aspiration cytology.
Hatem L; McIntire PJ; He B; Gogineni S; Ho M; Mathew S; Margolskee EM; Siddiqui MT; Rao RA
Diagn Cytopathol; 2019 Mar; 47(3):160-165. PubMed ID: 30520251
[TBL] [Abstract][Full Text] [Related]
26. Osteosarcoma pleural effusion: A diagnostic challenge with some cytologic hints.
AbdullGaffar B
Diagn Cytopathol; 2021 Jan; 49(1):E40-E44. PubMed ID: 32749768
[TBL] [Abstract][Full Text] [Related]
27. Categorisation of serous effusions using the International System for Reporting Serous Fluid Cytopathology and assessment of risk of malignancy with diagnostic accuracy.
Ahuja S; Malviya A
Cytopathology; 2022 Mar; 33(2):176-184. PubMed ID: 34913541
[TBL] [Abstract][Full Text] [Related]
28. The international system for reporting serous fluid cytopathology-diagnostic categories and clinical management.
Pinto D; Chandra A; Crothers BA; Kurtycz DFI; Schmitt F
J Am Soc Cytopathol; 2020; 9(6):469-477. PubMed ID: 32620534
[TBL] [Abstract][Full Text] [Related]
29. Immunocytochemistry of effusions: Processing and commonly used immunomarkers.
Shidham VB; Janikowski B
Cytojournal; 2022; 19():6. PubMed ID: 35541029
[TBL] [Abstract][Full Text] [Related]
30. DNA flow cytometry of pleural effusions. Comparison with pathology for the diagnosis of malignancy.
Evans DA; Thornthwaite JT; Ng AB; Sugarbaker EV
Anal Quant Cytol; 1983 Mar; 5(1):19-27. PubMed ID: 6846965
[TBL] [Abstract][Full Text] [Related]
31. Metastatic sarcomas to pleural effusion: a 10-year large tertiary care center experience with emphasis on clinical features and cytomorphologic characteristics.
Saoud C; Ali SZ
J Am Soc Cytopathol; 2023; 12(3):216-228. PubMed ID: 36858854
[TBL] [Abstract][Full Text] [Related]
32. Renal medullary carcinoma involving serous cavity fluids: a cytomorphologic study of 12 cases.
Miller DL; Ribeiro EA; Roy-Chowdhuri S; Illei PB; Siddiqui MT; Ali SZ
J Am Soc Cytopathol; 2021; 10(2):187-196. PubMed ID: 32651128
[TBL] [Abstract][Full Text] [Related]
33. The Diagnostic Accuracy of Claudin-4 Immunochemistry in Differentiating Metastatic Carcinomas From Mesothelial Processes in Serous Effusion Cytology: A Systematic Review and Meta-analysis.
Kleinaki M; Vey JA; Awounvo S; Ishak A; Arnaouti M; Ryu HS; Nikas IP
Arch Pathol Lab Med; 2024 Jun; ():. PubMed ID: 38871358
[TBL] [Abstract][Full Text] [Related]
34. The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions.
Illei PB; Ladanyi M; Rusch VW; Zakowski MF
Cancer; 2003 Feb; 99(1):51-6. PubMed ID: 12589646
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic Utility of Epithelial Membrane Antigen (EMA) and Calretinin (CAL) in Effusion Cytology.
Nautiyal N; Bhardwaj A; Acharya S; Kishore S; Kudesia S
J Clin Diagn Res; 2017 May; 11(5):EC36-EC39. PubMed ID: 28658770
[TBL] [Abstract][Full Text] [Related]
36. Indian Academy of Cytologists Guidelines for Collection, Preparation, Interpretation, and Reporting of Serous Effusion Fluid Samples.
; Srinivasan R; Rekhi B; Rajwanshi A; Pathuthara S; Mathur S; Jain D; Gupta N; Gautam U; Rai N; Nijhawan VS; Iyer V; Dey P; Deb P; Prasoon D
J Cytol; 2020; 37(1):1-11. PubMed ID: 31942091
[TBL] [Abstract][Full Text] [Related]
37. Cytologic re-evaluation of negative effusions from patients with malignant mesothelioma.
Ascoli V; Bosco D; Carnovale Scalzo C
Pathologica; 2011 Dec; 103(6):318-24. PubMed ID: 22558888
[TBL] [Abstract][Full Text] [Related]
38. Cytohistological correlation in serous effusions using the newly proposed International System for Reporting Serous Fluid Cytopathology: Experience of an oncological center.
Lobo C; Costa J; Petronilho S; Monteiro P; Leça L; Schmitt F
Diagn Cytopathol; 2021 May; 49(5):596-605. PubMed ID: 32339444
[TBL] [Abstract][Full Text] [Related]
39. A retrospective analysis of serous effusions based on the newly proposed international system for reporting serous fluid cytopathology: a report of 3633 cases in an oncological center.
Zhu YL; Ren WH; Wang Q; Jin HZ; Guo YY; Lin DM
Diagn Pathol; 2022 Jul; 17(1):56. PubMed ID: 35780135
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic utility of GLUT-1 expression in the cytologic evaluation of serous fluids.
Afify A; Zhou H; Howell L; Paulino AF
Acta Cytol; 2005; 49(6):621-6. PubMed ID: 16450901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
